1
|
Pongphitcha P, Sasanakul W, Kadegasem P, Songdej D, Limwongse C, Amesbutr M, Jaovisidha S, Chuansumrit A, Sirachainan N. Alleviated bleeding phenotypes in a child with severe haemophilia A and thalassemia disease. Haemophilia 2024. [PMID: 38783522 DOI: 10.1111/hae.15041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Revised: 04/22/2024] [Accepted: 05/12/2024] [Indexed: 05/25/2024]
Affiliation(s)
- Pongpak Pongphitcha
- Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Werasak Sasanakul
- Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Praguywan Kadegasem
- Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Duantida Songdej
- Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Chanin Limwongse
- Siriraj Genomics, Office of the Dean, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Mattana Amesbutr
- Siriraj Genomics, Office of the Dean, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Suphaneewan Jaovisidha
- Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Ampaiwan Chuansumrit
- Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Nongnuch Sirachainan
- Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| |
Collapse
|
2
|
Laoaroon N, Empremsilapa S, Sirachainan N. Pediatric standardized bleeding assessment tool for screening bleeding disorder in school-age children. Hematol Transfus Cell Ther 2022; 44:453-455. [PMID: 35110001 PMCID: PMC9477776 DOI: 10.1016/j.htct.2021.11.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Revised: 09/02/2021] [Accepted: 11/19/2021] [Indexed: 11/30/2022] Open
Affiliation(s)
- Napat Laoaroon
- Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
| | | | - Nongnuch Sirachainan
- Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
| |
Collapse
|
3
|
Moonla C, Akkawat B, Kittikalayawong Y, Sukperm A, Meesanun M, Uaprasert N, Sosothikul D, Rojnuckarin P. Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center. Clin Appl Thromb Hemost 2019; 25:1076029619866916. [PMID: 31359769 PMCID: PMC6829631 DOI: 10.1177/1076029619866916] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Correlations between bleeding symptoms and von Willebrand factor (VWF) levels may help to
predict hemorrhagic severity in the Westerners with von Willebrand disease (VWD), but data
in Asians are lacking. In this study, Thai patients with VWF levels <50 IU/dL without
any secondary causes were enrolled from 1988 to 2018 to determine the relationship between
VWF levels and hemorrhagic manifestations. According to the current concept, we
reclassified VWD and low VWF by VWF levels ≤30 and 30 to 50 IU/dL, respectively. Type 2
VWD was diagnosed if VWF activity to antigen ratio was ≤0.6. Bleeding severity was
determined by the condensed MCMDM-1VWD bleeding score (BS). Among 83 patients, VWF
activities showed negative correlations with BS (P = .001), which were
higher in type 2 (median: 7, interquartile range [IQR]: 5-11) compared with type 1 VWD
(median: 3, IQR: 2-4) and low VWF (median: 4, IQR: 2-8). Bleeding symptoms were
indistinguishable between type 1 VWD and low VWF using the 30 IU/dL cutoff point. However,
VWF ristocetin cofactor activity or gain-of-function mutant glycoprotein Ib binding
activity <36.5 IU/dL and VWF collagen binding activity <34.5 IU/dL could predict
increased bleeding risk (BS ≥3) by 92.3% specificity and 70.0% sensitivity
(P < .0001).
Collapse
Affiliation(s)
- Chatphatai Moonla
- 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.,2 Research Collaborations in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| | - Benjaporn Akkawat
- 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.,2 Research Collaborations in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| | - Yaowaree Kittikalayawong
- 3 Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| | - Autcharaporn Sukperm
- 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.,2 Research Collaborations in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| | - Mukmanee Meesanun
- 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.,2 Research Collaborations in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| | - Noppacharn Uaprasert
- 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.,2 Research Collaborations in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| | - Darintr Sosothikul
- 3 Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| | - Ponlapat Rojnuckarin
- 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.,2 Research Collaborations in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
| |
Collapse
|